Case presentation
An 85-year-old man was referred to the hospital for the evaluation of renal failure. Patient had the complaint of edema of lower extremities, dyspnea on exertion, skin lesions, nausea and vomiting. He also complained of orthopnea and cough. In the past medical history, he had the history of diabetes, hypertension and coronary artery disease (CAD). He had undergone coronary angiography three months before admission. Patient's complaints gradually increased after angiography. The patient was admitted with blood pressure of 100/80 mmHg and crackles in the base of the lungs. There was livedo reticularis on the feet ( Figure 1A ). His initial investigations showed hemoglobin of 8 g/dl and serum creatinine of 10 mg/dl. The urinalysis was bland. Ejection fraction on Doppler echocardiography was 25-30%, and pulmonary artery pressure was 75 mmHg. Given the history of angiography and the onset of symptoms following the procedure, a clinical diagnosis of contrast induced kidney injury was contemplated. A temporary jugular access was inserted and hemodialysis was started. After five dialysis sessions and improvement of his condition, the patient was scheduled for renal biopsy. In the semi-recumbent position, a kidney biopsy was performed. On the renal biopsy, glomeruli had normal morphology and architecture ( Figure 1B) . Interstitium exhibited edema, infiltration, fibrosis and tubular atrophy (~ 30%) ( Figure 1C ). The tubular epithelial cells showed marked degenerative changes and there was tubular dilatation. Interlobular and arcuate arteries showed a peri-vascular infiltration, fibrosis and luminal occlusion. The lumina showed prominent needle-like clefts and mild inflammatory cell infiltration ( Figure 1D ). Immunofluorescence (IF) studies for IgA, IgG, IgM, C3, C1q and fibrin were negative. The diagnosis was entirely consistent with atheroembolic disease, hence patient's supportive care and dialysis was continued. Two months after discharge, the patient died at home.
Discussion
Fenger, a Danish physician and his colleagues, described this disease for the first time in 1844 (1). The disease is the result of showers of cholesterol crystals released by ruptured atherosclerotic plaques (1-3). The disease may occur by spontaneous embolization or after angiographic procedures. The syndrome of cholesterol embolization has various clinical features (2-4). It may lead to acute, subacute or chronic kidney injury, skin emboli or gut ischemia. Skin manifestations which are most commonly livedo reticularis and blue toe syndrome are usually limited to the lower extremities (1) (2) (3) (4) (5) . In fact, cholesterol crystals trigger an inflammatory reaction after they lodge in the small arteries of the target organs including kidneys (3) (4) (5) (6) . Various constitutional symptoms and signs consisting of fever, anorexia, fatigue, weight loss and myalgia are usually the manifestations of the inflammatory response (4-7). Kidney biopsy seems to be a reliable diagnostic tool in patients with atheroembolic disease. However, the typical lesion, such as blockage of small arteries, arterioles, and the glomerular capillaries, usually are focal, and can be easily overlooked, if not carefully looked for. The classic lesion in atheroembolic disease is the occlusion of interlobular/arcuate arteries, small arteries, arterioles and the glomerular capillaries with cholesterol emboli (2) (3) (4) (5) . The emboli of cholesterol crystals generally are defined by the characteristic biconvex, needleshaped clefts appearing as "ghosts" (Figure 2A-D) . The crystals normally are dissolved during routine histologic preparation (3) (4) (5) (6) (7) . The prognosis in this disease is generally considered to be very poor. The reported mortality varies from 64 to 81% (4-9), depending on a number of factors, such as age and cardiovascular status. A variety of therapeutic modalities are used with conflicting results on their beneficial effects. A focus on early diagnosis and more efficient therapeutic and preventive strategies are therefore needed.
